Health
Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate – News-Medical.Net
New research deals with the development of RBD trimer as a potent target for SARS-CoV-2 subunit vaccines. This study revealed the development of a trimeric RBD…
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. This virus has infected more than 128 million individuals and has claimed about 2.8 million lives.
Several COVID-19 vaccines have been approved by various regulatory bodies and are currently being rolled out across many parts of the world. There are more than 200 COVID-19 vaccines under development, and 70 are undergoing clinical trials. Several…
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General15 hours agoFrench far-right supporters rally against Le Pen conviction in Paris
-
General22 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m